CG
Carter Gould Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
12%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
71.4%
Neutral
28.6%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Staples
Healthcare
Technology
Consumer Staples
Education & Training Services
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $315 |
5%
downside
| 2 | – |
–
| 6 Nov ‘25 29 days ago |
|
|
|
Overweight
Maintained
| $112 |
2%
upside
| 1 | +12% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $985 |
3%
downside
| 3 | +10% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $135 |
11%
upside
| 2 | +7.9% |
0
%
| 31 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $740 |
3%
upside
| 2 | +13% |
0
%
| 29 Oct ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $245 |
8%
upside
| 2 | +16% |
0
%
| 15 Sep ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $485 |
6%
upside
| 3 | -1.5% |
0
%
| 5 Aug ‘25 4 months ago |
|
|
|
Neutral
Reiterated
| $55 |
5%
upside
| 2 | +9.3% |
–
| 23 Apr ‘25 7 months ago |
|
|
|
Neutral
Initiated
| $24 |
8%
downside
| 1 | – |
–
| 22 Apr ‘25 7 months ago |
|
|
|
Overweight
Initiated
| – | – | 1 | +53% |
0
%
| 22 Apr ‘25 7 months ago |
|
|
|
Neutral
Initiated
| $85 |
15%
downside
| 1 | -29% |
–
| 22 Apr ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $165 |
6%
upside
| 1 | +15% |
0
%
| 23 Dec ‘24 11 months ago |
|